Table 3 Prediction of the occurrence of myelodysplastic syndrome (age< 65).
Crude | p value | Adjusted | p value | |
|---|---|---|---|---|
sHR* (95% CI) | sHR* (95% CI) | |||
ESRD versus non-ESRD | 2.34 (1.53–3.58) | 0.0001 | 2.45 (1.55–3.88) | 0.0001 |
Age | 1.01 (0.99–1.03) | 0.2104 | 1.01 (0.99–1.03) | 0.5405 |
IDA | 1.47 (0.68–3.17) | 0.3293 | 0.99 (0.45–2.18) | 0.9743 |
Anemia | 1.50 (0.93–2.42) | 0.0964 | 0.86 (0.51–1.46) | 0.5817 |
Charlson comorbidities | ||||
Myocardial infarction | 1.51 (0.21–10.82) | 0.6837 | 1.26 (0.17–9.17) | 0.8222 |
Congestive heart failure | 0.39 (0.05–2.79) | 0.3478 | 0.30 (0.04–2.17) | 0.2324 |
Peripheral vascular disease | 3.43 (1.08–10.84) | 0.0361 | 2.77 (0.86–8.90) | 0.0869 |
Cerebrovascular disease | 1.86 (0.94–3.71) | 0.0766 | 1.14 (0.51–2.55) | 0.7441 |
Dementia | 6.48 (0.90–46.55) | 0.0632 | 2.94 (0.38–22.78) | 0.3012 |
Chronic lung disease | 1.31 (0.73–2.36) | 0.3655 | 1.04 (0.56–1.93) | 0.9020 |
Connective tissue disease | 1.21 (0.30–4.92) | 0.7888 | 1.15 (0.28–4.70) | 0.8451 |
Ulcer | 1.68 (1.07–2.63) | 0.0242 | 1.44 (0.89–2.34) | 0.1390 |
Chronic liver disease | 1.52 (0.86–2.69) | 0.1483 | 1.30 (0.72–2.35) | 0.3905 |
Diabetes | 1.47 (0.85–2.52) | 0.1667 | 1.20 (0.66–2.18) | 0.5497 |
Diabetes with end-organ damage | 1.64 (0.52–5.18) | 0.4013 | 1.13 (0.33–3.82) | 0.8456 |
Hemiplegia | 4.94 (1.56–15.63) | 0.0066 | 3.43 (0.93–12.56) | 0.0631 |
Tumor, leukemia, lymphoma | 2.64 (1.33–5.25) | 0.0057 | 2.48 (1.23–5.00) | 0.0113 |
Moderate or severe liver disease | NA | NA | ||
Malignant tumor, metastasis | NA | NA | ||
AIDS | NA | NA | ||
